The Role of Cetuximab and Other Epidermal Growth Factor Receptor Monoclonal Antibodies in the Treatment of Advanced Non-Small Cell Lung Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|3|3|217-227

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.3, Iss.3, 2008-09, pp. : 217-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epidermal Growth Factor Receptor Inhibition and Non-Small Cell Lung cancer

By von Eyben Finn  

Critical Reviews in Clinical Laboratory Sciences, Vol. 43, Iss. 4, 2006-08 ,pp. : 291-323

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 33, Iss. 12, 2010-11 ,pp. : 704-709

Karger

Access to resources Recommend Favorite

Management of acquired resistance to epidermal growth factor receptor kinase inhibitors in patients with advanced non‐small cell lung cancer

By  

CANCER, Vol. 120, Iss. 15, 2014-08 ,pp. : 2289-2298

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer

By  

Oncology, Vol. 91, Iss. 1, 2016-07 ,pp. : 26-34

Karger

Access to resources Recommend Favorite

A comparison of epidermal growth factor receptor mutation testing methods in different tissue types in non-small cell lung cancer

By                    

International Journal of Molecular Medicine, Vol. 34, Iss. 2, 2014-01 ,pp. : 464-474

Spandidos Publications

Access to resources Recommend Favorite